Here's another paper that shows why reading only an abstract
can sometimes be misleading.
A prospective trial (abstract
here) of 49 patients randomized to single-incision
laparoscopic cholecystectomy (SILC) vs. 51 who had standard 4-port laparoscopic
cholecystectomy (LC) found that average operative times were
63.5 ± 21.0 minutes for the SILC compared to
43.8 ± 24.2 minutes for those who had LC, and hospital charges were also more
than $4000 higher for the SILC patients—both significant differences with p values
< 0.0001.
Medical and
surgical supplies were the major factors contributing to the increased charges
for SILC.
Other than a significantly larger number of females in the
SILC group, the patients were similar in baseline characteristics.
Other important considerations such as postoperative pain,
hospital length of stay (an average of 24 hours or less for both operations),
use of analgesics, cosmetic appearance of the wounds, rates of incisional
hernia, and quality of life were similar. Average follow-up was 16 months in
both groups. The authors concluded that there was no advantage to SILC.
Since this paper supports my bias against single-incision
surgery, I was going to tout it as yet another negative paper like a recent
meta-analysis (
here) from a group in Croatia showing absolutely no advantage
for SILC.
But
this sentence from the "Methods" section of the paper foiled my plan.
"Before partaking in the study,
each surgeon developed his or her SILC technical skills in a laboratory setting
and demonstrated proficiency during 5 SILCs under the supervision of a surgeon
with experience on more than 50 SILC cases."
This was not mentioned in the abstract.
Are you surprised that a surgeon that might take longer to
do SILC, an operation done only 5 times before, than LC, which each of the
surgeons had probably done hundreds of times? Although the mean operative
duration was longer for SILC, it is a "straw man" in statistical
parlance. This may not detract from the rest of the results but certainly has
to be considered.
As noted by the authors, the study was underpowered (that
is, there weren't enough patients) to detect differences in some of the other
outcomes due to difficulty recruiting subjects.
Of 946 patients offered enrollment in the study, only 103
consented. Patients declined to participate either because the surgeon explained
that he had done more standard LC procedures, or the patients opted for the
SILC because of its supposed cosmetic advantage.
The authors, based at Northwestern University Medical School
in Chicago, should be commended for their honesty in explaining their inexperience
with SILC to potential subjects of the trial and wonder if other surgeons who
perform SILC do this.
This paper also highlights the problems associated with
attempts to conduct randomized prospective studies involving new surgical
procedures.
Bottom line: The extra costs associated with SILC are not
worth it.
Part 1 of this 2-part series on SILC appeared on Tuesday,
2/18.